EMeRG Launches Hospital Intel Suite™️ to transform MedTech Market

Date:

Share post:

EMeRG, a leading healthcare intelligence provider with over a decade of industry expertise,  announced the launch of Hospital Intel Suite™, one of the world’s largest hospital intelligence platforms designed to transform how medical technology companies navigate commercial opportunities. 

Built on seven years of targeted development and EMeRG’s 12-year history of supporting leading MedTech organizations, the platform integrates artificial intelligence and predictive analytics with deep, granular data. Hospital Intel Suite™ delivers  visibility into hospital capabilities, specialized care areas, installed base intelligence, market sizing, and opportunity mapping.

By making hospital-level intelligence accessible, the platform enables global MedTech corporations, fast-growing startups, consulting firms, and healthcare investors to accurately segment markets, identify high-impact target hospitals, and accelerate commercial growth.

“Our mission has always been to make every hospital visible so that innovative and affordable medical technologies can reach where they make the greatest impact,” said the EMeRGleadership team. “Hospital Intel Suite™ democratizes high-level market intelligence, empowering organizations of all sizes to make smarter, data-driven decisions.”

Written by: Pragna Biswas

Graphics by: Pramit Hazra

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related articles

Bhawanipur Global Campus Announces iNATCONPH 2026: A Global Platform for Pharmacy & Allied Health Research

Kolkata: Bhawanipur Global Campus has announced the 16th International Conference - iNATCONPH 2026, a prestigious international scientific conference...

Emcure Pharma Receives CDSCO Approval to Launch Poviztra®️ for Fatty Liver Disease Treatment

Emcure Pharmaceuticals Ltd  announced that its co-marketed semaglutide brand, Poviztra®, has received regulatory approval from the Central Drugs...

CDSCO Partners with THSTI to Strengthen Vaccine and Healthcare innovation

The Central Drugs Standard Control Organization (CDSCO), India’s national regulatory authority, and the Translational Health Science and Technology...

CDSCO Issues Final Guidance for Medical Device Software Under MDR 2017

The Central Drugs Standard Control Organisation (CDSCO), functioning under the Directorate General of Health Services, Ministry of Health...